Patents by Inventor Patrick Bosché

Patrick Bosché has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATIONS CONTAINING FLAVOURING SUBSTANCES WITH IMPROVED PHARMACEUTICAL
    Publication number: 20110065719
    Abstract: The invention relates to flavouring-containing pharmaceutical formulations with improved pharmaceutical properties, and to process for the production thereof.
    Type: Application
    Filed: November 19, 2010
    Publication date: March 17, 2011
    Applicant: BAYER ANIMAL HEALTH GMBH
    Inventors: Patrick Bosché, Sabine Bongaerts, Venkata-Rangarao Kanikanti
  • Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties
    Patent number: 7858120
    Abstract: The invention relates to flavoring-containing pharmaceutical formulations with improved pharmaceutical properties, and to process for the production thereof.
    Type: Grant
    Filed: October 30, 2004
    Date of Patent: December 28, 2010
    Assignee: Bayer Animal Health GmbH
    Inventors: Patrick Bosché, Sabine Bongaerts, Venkata-Rangarao Kanikanti
  • Pharmaceutical moxifloxacin preparation
    Patent number: 6610327
    Abstract: The present invention relates to a pharmaceutical preparation for oral administration which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its preparation, and to the use of this preparation for controlling bacterial infections in humans and animals.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: August 26, 2003
    Assignee: Bayer Aktiengesellschaft
    Inventors: Patrick Bosché, Hans Friedrich Mahler, Claus Weisemann
  • Osmotic medicament releasing system
    Patent number: 6294201
    Abstract: This invention relates to an orally administered osmotic drug release system that consists of a shell and a core containing a pharmaceutically active substance, as well as a process for its production. The invention relates further to an osmotic drug release system for use as a drug in human beings and animals, as well as the use of the osmotic drug release system in the production of a drug for the treatment and/or prevention of illnesses in human beings and animals.
    Type: Grant
    Filed: April 25, 2000
    Date of Patent: September 25, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Stefan Kettelhoit, Ranga-Rao Kanikanti, Erich Brendel, Claus Weisemann, Ernst Chantraine, Michael Eisele, Patrick Bosché
  • Medicament formulation with a controlled release of an active agent
    Patent number: 6270799
    Abstract: The invention relates to drug formulations which comprise 1-cyclopropyl-7-([S,S]-2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quino-lonecarboxylic acid and/or pharmaceutically tolerable salts thereof and/or hydrates thereof as active compound which release the active compound they contain at a defined release rate.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: August 7, 2001
    Assignee: Bayer Aktiengesellscahft
    Inventors: Hans-Martin Siefert, Patrick Bosché, Heino Stass, Stefan Kettelhoit, Tobias Laich